| NCT01873326 |
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT01873326 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-06-30 |
| NCT04195555 |
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT04195555 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT04035447 |
Symptom Management for YA Cancer Survivors |
https://ClinicalTrials.gov/show/NCT04035447 |
Recruiting |
Duke University |
2025-10-01 |
| NCT03698994 |
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03698994 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT03526250 |
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03526250 |
Recruiting |
National Cancer Institute (NCI) |
2025-06-30 |
| NCT04222972 |
AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive, Metastatic NSCLC |
https://ClinicalTrials.gov/show/NCT04222972 |
Recruiting |
Blueprint Medicines Corporation |
2023-09-30 |
| NCT03158064 |
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT03158064 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-11-30 |
| NCT03067181 |
Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT03067181 |
Recruiting |
Children’s Oncology Group |
2027-06-30 |
| NCT03037385 |
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03037385 |
Recruiting |
Blueprint Medicines Corporation |
2021-12-31 |
| NCT03012620 |
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types |
https://ClinicalTrials.gov/show/NCT03012620 |
Recruiting |
UNICANCER |
2023-01-31 |
| NCT03233204 |
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03233204 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02875314 |
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors |
https://ClinicalTrials.gov/show/NCT02875314 |
Recruiting |
Nationwide Children’s Hospital |
2020-09-30 |
| NCT02860819 |
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT02860819 |
Recruiting |
National Cancer Institute, Slovakia |
2019-12-31 |
| NCT02859415 |
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases |
https://ClinicalTrials.gov/show/NCT02859415 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2028-08-03 |
| NCT03213704 |
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213704 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02797626 |
Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST) |
https://ClinicalTrials.gov/show/NCT02797626 |
Recruiting |
Heinrich-Heine University, Duesseldorf |
2021-06-30 |
| NCT02784054 |
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor |
https://ClinicalTrials.gov/show/NCT02784054 |
Recruiting |
Samsung Medical Center |
2021-03-31 |
| NCT03213678 |
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213678 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT03213665 |
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213665 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT03213652 |
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213652 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02582697 |
Accelerated v’s Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours |
https://ClinicalTrials.gov/show/NCT02582697 |
Recruiting |
University of Sydney |
2022-02-28 |
| NCT03155620 |
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT03155620 |
Recruiting |
National Cancer Institute (NCI) |
2027-09-30 |
| NCT03403777 |
Avelumab in Refractory Testicular Germ Cell Cancer. |
https://ClinicalTrials.gov/show/NCT03403777 |
Completed |
National Cancer Institute, Slovakia |
2019-02-28 |
| NCT02536183 |
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02536183 |
Recruiting |
Children’s National Research Institute |
2020-10-31 |
| NCT02533765 |
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor |
https://ClinicalTrials.gov/show/NCT02533765 |
Active, not recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2018-09-30 |
| NCT02429687 |
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT02429687 |
Recruiting |
Shandong University |
2021-05-31 |
| NCT02429466 |
Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT02429466 |
Active, not recruiting |
Indiana University |
2018-12-31 |
| NCT02414685 |
First Line TIP in Poor Prognosis TGCTs. |
https://ClinicalTrials.gov/show/NCT02414685 |
Recruiting |
National Cancer Institute, Slovakia |
2019-12-31 |
| NCT02375204 |
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT02375204 |
Recruiting |
Alliance for Clinical Trials in Oncology |
2024-06-30 |
| NCT02340884 |
A Pilot RCT of the PRISM Intervention for AYAs With Cancer |
https://ClinicalTrials.gov/show/NCT02340884 |
Active, not recruiting |
Seattle Children’s Hospital |
2017-09-19 |
| NCT02317393 |
Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy |
https://ClinicalTrials.gov/show/NCT02317393 |
Recruiting |
Centre Francois Baclesse |
2020-03-31 |
| NCT02161692 |
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT02161692 |
Completed |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2007-05-31 |
| NCT02122185 |
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT02122185 |
Recruiting |
University of Chicago |
2021-02-25 |
| NCT02104986 |
A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent |
https://ClinicalTrials.gov/show/NCT02104986 |
Recruiting |
Centre Leon Berard |
2021-05-31 |
| NCT02095132 |
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02095132 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-04-30 |
| NCT02076906 |
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors |
https://ClinicalTrials.gov/show/NCT02076906 |
Recruiting |
Children’s National Research Institute |
2020-10-31 |
| NCT01270724 |
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) |
https://ClinicalTrials.gov/show/NCT01270724 |
Completed |
Nationwide Children’s Hospital |
2019-10-23 |
| NCT01966913 |
Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT01966913 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2019-03-31 |
| NCT01851200 |
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT01851200 |
Completed |
Fondazione Michelangelo |
2017-08-31 |
| NCT01846520 |
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers |
https://ClinicalTrials.gov/show/NCT01846520 |
Completed |
City of Hope Medical Center |
2019-05-23 |
| NCT01782339 |
A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis |
https://ClinicalTrials.gov/show/NCT01782339 |
Recruiting |
Barts & The London NHS Trust |
2021-01-31 |
| NCT01764802 |
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer |
https://ClinicalTrials.gov/show/NCT01764802 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-06-01 |
| NCT01736917 |
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT01736917 |
Completed |
Hoosier Cancer Research Network |
2015-03-31 |
| NCT01726374 |
Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours |
https://ClinicalTrials.gov/show/NCT01726374 |
Active, not recruiting |
Institute of Cancer Research, United Kingdom |
2016-08-31 |
| NCT01696994 |
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) |
https://ClinicalTrials.gov/show/NCT01696994 |
Active, not recruiting |
National Cancer Institute (NCI) |
2012-05-21 |
| NCT01602666 |
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT01602666 |
Active, not recruiting |
Children’s Oncology Group |
2019-09-30 |
| NCT01484015 |
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT01484015 |
Completed |
Wake Forest University Health Sciences |
2012-06-30 |
| NCT01466231 |
Everolimus in Refractory Testicular Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT01466231 |
Completed |
National Cancer Institute, Slovakia |
2015-06-30 |
| NCT01322802 |
Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01322802 |
Active, not recruiting |
University of Washington |
2015-01-09 |
| NCT04402593 |
Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC: A Pilot Study |
https://ClinicalTrials.gov/show/NCT04402593 |
Active, not recruiting |
Indiana University |
2021-12-31 |
| NCT03950830 |
Disulfiram and Cisplatin in Refractory TGCTs. |
https://ClinicalTrials.gov/show/NCT03950830 |
Recruiting |
National Cancer Institute, Slovakia |
2021-12-31 |
| NCT03760081 |
A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT03760081 |
Recruiting |
Astellas Pharma Inc |
2022-09-30 |
| NCT03434262 |
SJDAWN: St. Jude Children’s Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT03434262 |
Recruiting |
St. Jude Children’s Research Hospital |
2025-02-28 |
| NCT03426865 |
Role of Axumin PET Scan in Germ Cell Tumor |
https://ClinicalTrials.gov/show/NCT03426865 |
Completed |
University of Texas Southwestern Medical Center |
2019-12-30 |
| NCT03418844 |
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy |
https://ClinicalTrials.gov/show/NCT03418844 |
Recruiting |
Centre Francois Baclesse |
2020-06-30 |
| NCT01242631 |
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT01242631 |
Completed |
Hannover Medical School |
2014-03-31 |
| NCT01155258 |
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT01155258 |
Completed |
University of Southern California |
2013-01-31 |
| NCT01131234 |
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT01131234 |
Completed |
National Cancer Institute (NCI) |
2014-09-30 |
| NCT01126346 |
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) |
https://ClinicalTrials.gov/show/NCT01126346 |
Completed |
Wake Forest University Health Sciences |
2011-04-30 |
| NCT01079832 |
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies |
https://ClinicalTrials.gov/show/NCT01079832 |
Completed |
Case Comprehensive Cancer Center |
2012-05-31 |
| NCT01076530 |
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors |
https://ClinicalTrials.gov/show/NCT01076530 |
Completed |
National Cancer Institute (NCI) |
2012-10-31 |
| NCT01055067 |
ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT01055067 |
Completed |
Daiichi Sankyo, Inc. |
2011-11-30 |
| NCT01049230 |
Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT01049230 |
Active, not recruiting |
Massachusetts General Hospital |
2020-03-31 |
| NCT01037790 |
PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER |
https://ClinicalTrials.gov/show/NCT01037790 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2019-10-31 |
| NCT00994500 |
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma |
https://ClinicalTrials.gov/show/NCT00994500 |
Completed |
National Cancer Institute (NCI) |
2011-07-31 |
| NCT00957905 |
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00957905 |
Completed |
National Cancer Institute (NCI) |
2014-08-31 |
| NCT00936936 |
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors |
https://ClinicalTrials.gov/show/NCT00936936 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-10-15 |
| NCT00929903 |
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment |
https://ClinicalTrials.gov/show/NCT00929903 |
Completed |
National Cancer Institute (NCI) |
2013-04-30 |
| NCT00864318 |
Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis |
https://ClinicalTrials.gov/show/NCT00864318 |
Active, not recruiting |
Institut Claudius Regaud |
2021-09-30 |
| NCT03911388 |
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors |
https://ClinicalTrials.gov/show/NCT03911388 |
Recruiting |
University of Alabama at Birmingham |
2023-09-01 |
| NCT03081923 |
Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT03081923 |
Recruiting |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2019-12-31 |
| NCT02834013 |
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
https://ClinicalTrials.gov/show/NCT02834013 |
Recruiting |
National Cancer Institute (NCI) |
2021-08-31 |
| NCT00788125 |
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors |
https://ClinicalTrials.gov/show/NCT00788125 |
Active, not recruiting |
City of Hope Medical Center |
2023-09-30 |
| NCT00716976 |
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy |
https://ClinicalTrials.gov/show/NCT00716976 |
Completed |
Children’s Oncology Group |
2015-04-30 |
| NCT00638898 |
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor |
https://ClinicalTrials.gov/show/NCT00638898 |
Active, not recruiting |
City of Hope Medical Center |
2020-09-01 |
| NCT00611962 |
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin |
https://ClinicalTrials.gov/show/NCT00611962 |
Completed |
Sanofi |
NA |
| NCT00572572 |
Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00572572 |
Completed |
Hoosier Cancer Research Network |
2010-12-31 |
| NCT00470366 |
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00470366 |
Completed |
Memorial Sloan Kettering Cancer Center |
2016-06-30 |
| NCT00467051 |
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00467051 |
Completed |
Children’s Oncology Group |
2012-03-01 |
| NCT00453310 |
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment |
https://ClinicalTrials.gov/show/NCT00453310 |
Completed |
Memorial Sloan Kettering Cancer Center |
2008-11-30 |
| NCT00453232 |
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00453232 |
Completed |
National Cancer Institute (NCI) |
2008-12-31 |
| NCT00019578 |
Stereotactic Radiosurgery in Treating Patients With Brain Tumors |
https://ClinicalTrials.gov/show/NCT00019578 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00436254 |
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00436254 |
Active, not recruiting |
University of Washington |
2010-03-31 |
| NCT00432094 |
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00432094 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2020-08-31 |
| NCT00423852 |
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin |
https://ClinicalTrials.gov/show/NCT00423852 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-02-28 |
| NCT00410657 |
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00410657 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-11-30 |
| NCT00408681 |
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00408681 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-11-30 |
| NCT00408655 |
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00408655 |
Completed |
National Cancer Institute (NCI) |
2012-01-31 |
| NCT00393861 |
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients |
https://ClinicalTrials.gov/show/NCT00393861 |
Completed |
Indiana University |
2012-10-31 |
| NCT00387920 |
Sunitinib in Treating Young Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00387920 |
Completed |
National Cancer Institute (NCI) |
2012-09-30 |
| NCT00371553 |
Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT00371553 |
Completed |
British Columbia Cancer Agency |
2009-06-30 |
| NCT00324298 |
Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles |
https://ClinicalTrials.gov/show/NCT00324298 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00313599 |
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00313599 |
Completed |
University of California, San Francisco |
2013-12-31 |
| NCT00303940 |
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT00303940 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00301782 |
Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00301782 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00293384 |
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00293384 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2009-06-30 |
| NCT00293358 |
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain |
https://ClinicalTrials.gov/show/NCT00293358 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00281944 |
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00281944 |
Completed |
National Cancer Institute (NCI) |
2009-05-31 |
| NCT00228358 |
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient’s Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine |
https://ClinicalTrials.gov/show/NCT00228358 |
Completed |
University of Washington |
2011-05-31 |
| NCT00204633 |
Darbepoetin Alfa in Patients With “Poor Prognosis” Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) |
https://ClinicalTrials.gov/show/NCT00204633 |
Completed |
University Hospital Tuebingen |
2008-12-31 |
| NCT00187109 |
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy |
https://ClinicalTrials.gov/show/NCT00187109 |
Completed |
St. Jude Children’s Research Hospital |
2007-02-28 |
| NCT00183820 |
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00183820 |
Completed |
University of Southern California |
2015-12-31 |
| NCT00109993 |
Campath-1H + FK506 and Methylprednisolone for GVHD |
https://ClinicalTrials.gov/show/NCT00109993 |
Completed |
Case Comprehensive Cancer Center |
2006-06-30 |
| NCT00104676 |
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00104676 |
Active, not recruiting |
UNICANCER |
2012-03-29 |
| NCT00101270 |
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00101270 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00091182 |
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00091182 |
Completed |
National Cancer Institute (NCI) |
2006-02-28 |
| NCT00002489 |
Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00002489 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-06-30 |
| NCT00003982 |
MEN-10755 in Treating Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00003982 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
NA |
| NCT00003518 |
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00003518 |
Completed |
Eastern Cooperative Oncology Group |
2002-07-31 |
| NCT00002750 |
Melphalan in Patients With Neoplastic Meningitis |
https://ClinicalTrials.gov/show/NCT00002750 |
Completed |
Duke University |
2001-05-31 |
| NCT00082654 |
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients |
https://ClinicalTrials.gov/show/NCT00082654 |
Completed |
Fred Hutchinson Cancer Research Center |
2004-10-31 |
| NCT00002903 |
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT00002903 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
NA |
| NCT00004604 |
Biological Therapy in Treating Patients With Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00004604 |
Completed |
Duke University |
2001-06-30 |
| NCT00003887 |
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00003887 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00010283 |
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon |
https://ClinicalTrials.gov/show/NCT00010283 |
Completed |
Fred Hutchinson Cancer Research Center |
2002-07-31 |
| NCT00003107 |
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors |
https://ClinicalTrials.gov/show/NCT00003107 |
Completed |
Indiana University |
NA |
| NCT00007813 |
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors |
https://ClinicalTrials.gov/show/NCT00007813 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-02-01 |
| NCT00006043 |
Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin |
https://ClinicalTrials.gov/show/NCT00006043 |
Completed |
Memorial Sloan Kettering Cancer Center |
2001-11-30 |
| NCT00003657 |
High-dose ICE With Amifostine |
https://ClinicalTrials.gov/show/NCT00003657 |
Completed |
Dana-Farber Cancer Institute |
2000-11-30 |
| NCT00003014 |
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer |
https://ClinicalTrials.gov/show/NCT00003014 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002508 |
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00002508 |
Completed |
Temple University |
2001-09-30 |
| NCT00004157 |
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin’s Lymphoma, Hodgkin’s Disease, Breast Cancer, or Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT00004157 |
Completed |
Fred Hutchinson Cancer Research Center |
2002-04-30 |
| NCT00003811 |
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00003811 |
Completed |
Children’s Oncology Group |
2004-10-31 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00070096 |
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00070096 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002559 |
Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin |
https://ClinicalTrials.gov/show/NCT00002559 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-01-31 |
| NCT00002520 |
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer |
https://ClinicalTrials.gov/show/NCT00002520 |
Completed |
Eastern Cooperative Oncology Group |
2002-02-28 |
| NCT00066482 |
Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00066482 |
Completed |
Children’s Oncology Group |
2007-04-30 |
| NCT00064311 |
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00064311 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00003408 |
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00003408 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00060255 |
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors |
https://ClinicalTrials.gov/show/NCT00060255 |
Completed |
Roswell Park Cancer Institute |
2006-08-31 |
| NCT00003173 |
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00003173 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-05-31 |
| NCT00047320 |
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00047320 |
Completed |
Children’s Oncology Group |
2009-02-28 |
| NCT00045045 |
Positron Emission Tomography in Detecting Testicle Cancer |
https://ClinicalTrials.gov/show/NCT00045045 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00040911 |
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00040911 |
Completed |
Children’s Oncology Group |
2009-10-31 |
| NCT00036959 |
ABT-751 in Treating Young Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00036959 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-02-28 |
| NCT00036842 |
Arsenic Trioxide in Treating Men With Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT00036842 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00795769 |
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00795769 |
Completed |
Fred Hutchinson Cancer Research Center |
2009-06-09 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00028496 |
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00028496 |
Completed |
National Cancer Institute (NCI) |
2005-11-30 |
| NCT00024258 |
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors |
https://ClinicalTrials.gov/show/NCT00024258 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-05-31 |
| NCT00020150 |
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00020150 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019331 |
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT00019331 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006246 |
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer |
https://ClinicalTrials.gov/show/NCT00006246 |
Completed |
Pediatric Brain Tumor Consortium |
2003-05-31 |
| NCT00005952 |
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT00005952 |
Completed |
Duke University |
2005-11-30 |
| NCT00005590 |
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00005590 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004077 |
Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer |
https://ClinicalTrials.gov/show/NCT00004077 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003941 |
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT00003941 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2007-06-30 |
| NCT00003800 |
Diagnostic Study of Patients With Stage I Testicular Cancer |
https://ClinicalTrials.gov/show/NCT00003800 |
Completed |
Eastern Cooperative Oncology Group |
2004-12-31 |
| NCT00003420 |
CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy |
https://ClinicalTrials.gov/show/NCT00003420 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002943 |
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer |
https://ClinicalTrials.gov/show/NCT00002943 |
Completed |
Wake Forest University Health Sciences |
2003-10-31 |
| NCT00002931 |
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT00002931 |
Completed |
City of Hope Medical Center |
2014-12-31 |
| NCT00002596 |
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00002596 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002594 |
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00002594 |
Completed |
Children’s Oncology Group |
2003-09-30 |
| NCT00002558 |
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00002558 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-04-30 |
| NCT00002515 |
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer |
https://ClinicalTrials.gov/show/NCT00002515 |
Completed |
Memorial Sloan Kettering Cancer Center |
2005-04-30 |
| NCT00002472 |
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors |
https://ClinicalTrials.gov/show/NCT00002472 |
Completed |
Mayo Clinic |
2005-08-31 |
| NCT00030108 |
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven’t Responded to Therapy |
https://ClinicalTrials.gov/show/NCT00030108 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-03-31 |
| NCT00060372 |
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer |
https://ClinicalTrials.gov/show/NCT00060372 |
Completed |
National Cancer Institute (NCI) |
2008-04-30 |
| NCT00027534 |
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00027534 |
Completed |
Duke University |
2007-10-31 |